The Blood Transfusion Association (BTA) MDR Working Group, comprising Cerus, Fresenius, GVS, Haemonetics and Terumo BCT, supports the European Commissions efforts to simplify the Medical Devices Regulation (MDR) while safeguarding patient safety and ensuring the uninterrupted supply of blood products across Europe.
BTA
Blood Transfusion Association
Industry association · Belgium · EU Transparency Register 882567936674-26
5
positions filed
in the 665 files tracked
4
legislative files
of 665 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 665 consultation files tracked so far (57,774 submissions, mostly 2021–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1518 trade and business associations on this site, they rank #697 by legislative files engaged, a count of participation, not a measure of influence.
0.6
declared lobbying FTE
self-declared
€25K+
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2019
in the register since
- Register category
- Trade and business associations
- Head office
- Brussels, Belgium
Self-declared to the EU Transparency Register (snapshot 14 Oct 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Blood in PolicySpeak: request access →
Work at Blood Transfusion Association? so we know who speaks for it.
Their record over time
Blood Transfusion Association filed 5 positions between 14 Dec 2020 and 3 Aug 2026, across 4 of the 665 legislative files tracked here, attaching a full position paper 1 time.
2020 · 1 filed2021 · 1 filed2022 · 1 filed2023 · 1 filed2026 · 1 filed
What they argued
The Blood Transfusion Association (BTA), an international non-profit trade association committed to promoting the correct use and safe supply of blood for transfusion, welcomes the opportunity to provide feedback on the IIA of the REACH regulation. Over the years, blood supply has been hampered by population ageing, climate change, and more recently, COVID-19, due to the decrease in blood donations.
The Blood Transfusion Association (BTA) welcomes the Commissions recognition of the urgent risks of medical device shortages in Europe stemming from the challenges posed by the transitional provisions in the Medical Devices Regulation.
The Blood Transfusion Association (BTA) welcomes the European Commission’s proposal for a Regulation on Substances of Human Origin (SoHO) and the opportunity to provide feedback. The BTA is satisfied with the positive progress made with the proposal. However, we are eager to see improvement in certain areas of the proposal.
The Blood Transfusion Association (BTA) welcomes the European Commission’s Inception Impact Assessment (IIA) on the revision of the blood, tissues and cells (BTC) legislation and the opportunity to provide feedback. The BTA is an international non-profit trade association dedicated to supporting the correct use and safe supply of blood for transfusion to ensure patient safety.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Blood Transfusion Association next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers, not evidence of coordination, and we do not suggest any.
Showing 5 of 32.
Is this your organization?
Everything on this page comes from Blood Transfusion Association’s own submissions to the European Commission. We have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.